NC-318

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameNC-318
Drug Alias NameNC-3185G-12
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionSialic acid-binding Ig-like lectin 15 inhibitors
TargetsSialic acid-binding Ig-like lectin 15
Therapy Area/IndicationsSolid tumoursEndometrial NeoplasmsCarcinoma, Non-Small-Cell Lung +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesYale School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesYale UniversityNextcure Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursEndometrial NeoplasmsCarcinoma, Non-Small-Cell Lung +[10] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A